Summary
Islet cell antibodies are usually detected in the sera of almost all Type 1 (insulin-dependent) diabetic patients within several months after onset of the disease. The antibodies then disappear quite early during the course of the disease. The present study was undertaken to detect islet cell antibody-producing clones in peripheral blood lymphocytes of Type 1 diabetic patients whose islet cell antibodies could not be detected in sera. Epstein-Barr virus-transformed lymphocytes were employed to enhance the production of antibodies and to detect the clones from peripheral blood lymphocytes. Peripheral blood lymphocytes were obtained from 40 islet cell antibody-negative Type 1 diabetic patients, 10 antibody-positive Type 1 diabetic patients, 30 Type 2 (non-insulin-dependent) diabetic patients and 40 normal control subjects. Epstein-Barr virus-transformed lymphocytes were cultured for 4 weeks and the culture supernatants were used for assay of islet cell antibodies. Islet cell antibody assays were performed by immunohistochemical methods using peroxidase-labelled protein A for IgG antibodies, peroxidase-labelled anti-human IgM antibodies for IgM antibodies and fresh frozen human pancreatic tissue. IgG-islet cell antibodies were detected in 26 islet cell antibody-negative patients (65%), eight antibody-positive patients (80%) and one Type 2 diabetic patient (3%) in the culture supernatants. Islet cell antibodies in the supernatants could not be detected in any of the control subjects. IgM-islet cell antibodies could not be detected in any of the patients or control subjects. These findings indicate that islet cell antibody-producing clones exist in peripheral blood lymphocytes from Type 1 diabetic patients whose islet cell antibodies cannot be detected in their sera and IgG-islet cell antibodies might be a specific characteristic of Type 1 diabetes. The detection of islet cell antibodies from Epstein-Barr virus-transformed lymphocytes may be useful in examining the role of autoimmune mechanisms in the development of disease.
Article PDF
Similar content being viewed by others
References
Bottazzo GF, Florin-Christensen A, Doniach D (1974) Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiency. Lancet II: 1279–1282
Lendrum R, Walker G, Cudworth AG, Theophanides C, Pyke DA, Bloom A, Gamble DR (1976) Islet-cell antibodies in diabetes mellitus. Lancet I: 1273–1276
Bruining GJ, Molenaar J, Tuk CW, Lindeman J, Bruining HA, Marner B (1984) Clinical time-course and characteristics of islet cell cytoplasmic antibodies in childhood diabetes. Diabetologia 26: 24–29
Irvine WJ, McCallum CJ, Gray RS, Campbell CJ, Duncan LJP, Farquhar JW, Vaugham H, Morris PJ (1977) Pancreatic islet-cell antibodies in diabetes mellitus correlated with the duration and type of diabetes, coexistent autoimmune disease and HLA. Diabetes 26: 138–147
Bottazzo GF, Doniach D, Pouplard A (1976) Humoral autoimmunity in diabetes mellitus. Acta Endocrinol [Suppl 205] 83: 53–61
Del Prete GF, Betterle C, Padovan D, Erle G, Toffolo A, Bersahi G (1977) Incidence and significance of islet-cell autoantibodies in different types of diabetes mellitus. Diabetes 26: 909–915
Takahashi A, Tsujihata M, Yokota A, Yamaguchi Y, Ueda Y, Akazawa S, Miyake S, Nagataki S (1986) A new method of detection of islet cell antibodies (ICA) using peroxidase-labelled protein A, and incidence of ICA in Type 1 (insulin-dependent) diabetes. Diabetologia 29: 378–382
Miller G, Lipman M (1973) Release of infectious Epstein-Barr virus by transformed marmocet leukocytes. Proc Natl Acad Sci USA 70: 190–194
Prabhakar BS, Saegusa J, Onodera T, Notkins AL (1984) Lymphocytes capable of making monoclonal autoantibodies that react with multiple organs are a common feature of the normal B cell repertoire. J Immunol 133: 2815–2817
National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039–1057
Karnovsky MZ (1967) The ultrastructural basis of capillary permeability studied with a peroxidase tracer. J Cell Biol 35: 213–236
Boitard C, Bonifacio G, Bottazzo GF, Gleichmann H, Molenaar J (1988) Immunology and Diabetes Workshop: Report on the Third International (Stage 3) Workshop on the Standardization of Cytoplasmic Islet Cell Antibodies. Diabetologia 31: 451–452
Casali P, Nakamura M, Ginsberg-Feller F, Notkins AL (1990) Frequency of B cells committed to the production of antibodies to insulin in newly diagnosed patients with insulin-dependent diabetes mellitus and generation of high affinity human monoclonal IgG to insulin. J Immunol 144: 683–688
Tien-Wen T, Shao-Ling L, Kriss JP (1985) Peripheral blood lymphocytes from normal individuals can be induced to secrete immunoglobulin G antibodies against self-antigen thyroglobulin in vitro. J Clin Endocrinol Metab 60: 279–282
Lisak RP, Larmore C, Levinson AI, Zweiman B, Moskovits AR, White A (1984) In vitro synthesis of antibodies to acetylcholine receptor by peripheral blood cells: role of suppressor T cells in normal subjects. Neurology 34: 802–806
Kanazawa H, Eguchi K, Mine M, Ikari N, Kurata A, Fukuda T, Matsunaga M, Nagataki S (1986) Serum from patients with autoimmune diseases induces in vitro production of disease-associated antibodies by peripheral blood mononuclear cells from normal subjects. J Clin Endocrinol Metab 63: 683–688
Kirchner H, Tosato G, Blaese RM, Broder S, Magrath I (1979) Polyclonal immunoglobulin section by human B lymphocytes exposed to Epstein-Barr virus. J Immunol 118: 1310–1313
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yamaguchi, Y., Chikuba, N., Nakanishi, T. et al. Production of islet cell antibodies from Epstein-Barr virus-transformed peripheral blood lymphocytes in Type 1 (insulin-dependent) diabetic patients. Diabetologia 34, 511–514 (1991). https://doi.org/10.1007/BF00403288
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00403288